PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26322N0156DO for clinical chemistry and immunochemistry — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C26318A0025. PoP ended Sep 30, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 23 (36C263)
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Sep 30, 2022
PoP end
$391K
Obligated
$444K
Potential
334516
NAICS
6640
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal
Contract number36C26322N0156
Also listed as36C263-22-N-0156
Also listed as36C26318A0025-36C26322N0156
AgencyNetwork Contract Office 23 (36C263)
Awarding officeNetwork Contract Office 23 (36C263)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDV36C26318A0025
Place of performanceRARITAN NJ
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startOct 4, 2021
PoP end (current)Sep 30, 2022
Obligated$391K
Current value$444K
Potential value$444K

DO FOR CLINICAL CHEMISTRY AND IMMUNOCHEMISTRY is a federal award for Network Contract Office 23 (36C263) held by Ortho-Clinical Diagnostics, Inc. Estimated value $444K ($391K obligated). Current period of performance ends Sep 30, 2022. Place of performance: RARITAN NJ.

DO FOR CLINICAL CHEMISTRY AND IMMUNOCHEMISTRY

Recompete timing

Public
Past PoP end (1421 days ago)

Current PoP ended Sep 30, 2022 (1421 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same parent · incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26322N0156?

36C26322N0156 (DO for clinical chemistry and immunochemistry) is a Network Contract Office 23 (36C263) award with a potential value of $444K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C263-22-N-0156?

36C263-22-N-0156 is the dashed form of PIID 36C26322N0156 (DO for clinical chemistry and immunochemistry), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26322N0156?

Network Contract Office 23 (36C263) awarded 36C26322N0156 to Ortho-Clinical Diagnostics, Inc (potential $444K).

Who is the incumbent on 36C26322N0156?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.

When does Ortho-Clinical Diagnostics, Inc’s 36C26322N0156 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26322N0156